-

SHAREHOLDER ALERT: Robbins LLP Announces that Hyzon Motors Inc. (HYZN) f/k/a Decarbonization Plus Acquisition Corporation (DCRB) is Being Sued for Misleading Shareholders

SAN DIEGO--(BUSINESS WIRE)--Shareholder rights law firm Robbins LLP announces that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired Hyzon Motors Inc. (NASDAQ: HYZN, HYZNW) securities between February 9, 2021 and September 27, 2021, for violations of the Securities Exchange Act of 1934. Hyzon Motors Inc. purports to be the industry-leading global supplier of zero emissions hydrogen fuel cell powered commercial vehicles.

If you suffered a loss due to Hyzon Motors Inc.'s misconduct, click here.

Hyzon Motors Inc. (HYZN) Misrepresented its Customer List and Production Capabilities

According to the complaint, on February 9, 2021, Hyzon announced a business combination with Decarbonization Plus Acquisition Corporation (NASDAQ: DCRB). The announcement touted Hyzon's supply agreements, global reach, and expansion abilities. Throughout the class period, defendants hyped the Company's vehicle orders. Specifically, on August 11, 2021, "Hyzon affirmed 2021 sales outlook, including 85 vehicles to be shipped worldwide[.]" Then, on September 9, 2021, the Company announced it would "supply up to 500 hydrogen fuel cell electric vehicles to Shanghai logistics company," with 100 vehicles delivered before the end of 2021 and the other 400 delivered in 2022.

In reality, Hyzon was misrepresenting the nature of its customer contracts and embellishing its deals and partnerships with customers. The truth was revealed on September 28, 2021, when market analyst Blue Orca Capital published a report disclosing that, among other things: (1) Hyzon's largest customer is a fake-looking Chinese shell entity formed three days before the deal was announced; (2) Hyzon's purported largest customer was a "channel partner" assisting Hyzon in marketing vehicles to retail end customers in New Zealand; and (3) Hyzon misrepresented its big-name blue chip customers and failed to adjust its revenue projections. On this news, Hyzon shares fell $2.58 per share, or 28%, to close at $6.63 per share on September 28, 2021, damaging investors.

If you purchased shares of Hyzon Motors Inc (HYZN) between February 9, 2021 and September 27, 2021, you have until November 29, 2021, to ask the court to appoint you lead plaintiff for the class.

All representation is on a contingency fee basis. Shareholders pay no fees or expenses.

Contact us to learn more:

Aaron Dumas
(800) 350-6003
adumas@robbinsllp.com
Shareholder Information Form

About Robbins LLP: A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LLP have been dedicated to helping shareholders recover losses, improve corporate governance structures, and hold company executives accountable for their wrongdoing since 2002. To be notified if a class action against Hyzon Motors Inc. settles or to receive free alerts when corporate executives engage in wrongdoing, sign up for Stock Watch today.

Attorney Advertising. Past results do not guarantee a similar outcome.

Contacts

Aaron Dumas
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
adumas@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

Robbins LLP

NASDAQ:HYZN

Release Summary
Hyzon Motors Inc. (HYZN) Misrepresented its Customer List and Production Capabilities
Release Versions
$Cashtags

Contacts

Aaron Dumas
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
adumas@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

More News From Robbins LLP

Investor Notice: Shareholder Rights Law Firm Robbins LLP Informs Investors of the uniQure N.V. Securities Class Action Lawsuit

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired uniQure N.V. (NASDAQ: QURE) ordinary shares between September 24, 2025 and October 31, 2025. uniQure is a biotechnology company developing gene therapies for rare diseases. For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. The Allegations: Robbins LLP is Investigating Allegations that un...

Investor Notice: Shareholder Rights Law Firm Robbins LLP Informs Investors of the POMDoctor Ltd. Securities Class Action Lawsuit

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired POMDoctor, Ltd. (NASDAQ: POM) securities between October 9, 2025 and December 11, 2025. POMDoctor claims to be "a leading online medical services platform for chronic diseases in China." For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. The Allegations: Robbins LLP is Investigating Alleg...

Investor Notice: Shareholder Rights Law Firm Robbins LLP Informs Investors of the Inovio Pharmaceuticals, Inc. Class Action Lawsuit

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all persons that purchased or otherwise acquired Inovio Pharmaceuticals, Inc. (NASDAQ: INO) securities between October 10, 2023 and December 26, 2025. Inovio is a biotechnology company focused on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with, inter alia, human papillomavirus (“HPV”). For more information, submit a...
Back to Newsroom